Search research articles
Contact Us
Filters
Showing results (161-170 of 262) with videos related to
Page
of 27
Sort By:
Journal of Hematology & Oncology
|
January 21, 2017
Safety and efficacy of fruquintinib in patients with previously treated metastatic colorectal cancer: a phase Ib study and a randomized double-blind phase II study
Rui-Hua Xu, Jin Li, Yuxian Bai, et al.
Cell Death & Disease
|
November 28, 2025
AMPK phosphorylates WIP1 to promote DNA repair and radioresistance in cancer cells
Manman Lu, Xiaochuan Dong, Chunrui Wu, et al.
Cancer Science
|
August 27, 2021
Molecular profiling and identification of prognostic factors in Chinese patients with small bowel adenocarcinoma
Hongming Pan, Huanqing Cheng, Huina Wang, et al.
JCO Precision Oncology
|
February 14, 2024
Activity of Tepotinib in Hepatocellular Carcinoma With High-Level <i>MET</i> Amplification: Preclinical and Clinical Evidence
Shukui Qin, Hongming Pan, Jean Frédéric Blanc, et al.
Frontiers in Molecular Biosciences
|
July 26, 2021
Deep Sequencing of T-Cell Receptors for Monitoring Peripheral CD8<sup>+</sup> T Cells in Chinese Advanced Non-Small-Cell Lung Cancer Patients Treated With the Anti-PD-L1 Antibody
Jin Sheng, Huadi Wang, Xiao Liu, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|
May 16, 2024
IMpower210: A phase III study of second-line atezolizumab <i>vs.</i> docetaxel in East Asian patients with non-small cell lung cancer
Yi-Long Wu, Shun Lu, Gongyan Chen, et al.
Frontiers in Oncology
|
February 17, 2022
Exploring the Interobserver Agreement in Computer-Aided Radiologic Tumor Measurement and Evaluation of Tumor Response
Hongsen Li, Jiaying Shen, Jiawei Shou, et al.
Therapeutic Advances in Medical Oncology
|
April 7, 2023
A phase Ia dose-escalation trial of Ametumumab (a fully human monoclonal antibody against epidermal growth factor receptor) in patients with advanced solid malignancies
Da Li, Hong Pan, Wei Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 18, 2022
Alpha-Fetoprotein as a Potential Surrogate Biomarker for Atezolizumab + Bevacizumab Treatment of Hepatocellular Carcinoma
Andrew X Zhu, Farshid Dayyani, Chia-Jui Yen, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
February 22, 2014
Bevacizumab plus capecitabine and cisplatin in Chinese patients with inoperable locally advanced or metastatic gastric or gastroesophageal junction cancer: randomized, double-blind, phase III study (AVATAR study)
Lin Shen, Jin Li, Jianming Xu, et al.
Page
of 27
Search research articles
Search
Showing results (161-170 of 262) with videos related to
Sort By:
Page
of 27
Journal of Hematology & Oncology
|
January 21, 2017
Safety and efficacy of fruquintinib in patients with previously treated metastatic colorectal cancer: a phase Ib study and a randomized double-blind phase II study
Rui-Hua Xu, Jin Li, Yuxian Bai, et al.
Cell Death & Disease
|
November 28, 2025
AMPK phosphorylates WIP1 to promote DNA repair and radioresistance in cancer cells
Manman Lu, Xiaochuan Dong, Chunrui Wu, et al.
Cancer Science
|
August 27, 2021
Molecular profiling and identification of prognostic factors in Chinese patients with small bowel adenocarcinoma
Hongming Pan, Huanqing Cheng, Huina Wang, et al.
JCO Precision Oncology
|
February 14, 2024
Activity of Tepotinib in Hepatocellular Carcinoma With High-Level <i>MET</i> Amplification: Preclinical and Clinical Evidence
Shukui Qin, Hongming Pan, Jean Frédéric Blanc, et al.
Frontiers in Molecular Biosciences
|
July 26, 2021
Deep Sequencing of T-Cell Receptors for Monitoring Peripheral CD8<sup>+</sup> T Cells in Chinese Advanced Non-Small-Cell Lung Cancer Patients Treated With the Anti-PD-L1 Antibody
Jin Sheng, Huadi Wang, Xiao Liu, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu
|
May 16, 2024
IMpower210: A phase III study of second-line atezolizumab <i>vs.</i> docetaxel in East Asian patients with non-small cell lung cancer
Yi-Long Wu, Shun Lu, Gongyan Chen, et al.
Frontiers in Oncology
|
February 17, 2022
Exploring the Interobserver Agreement in Computer-Aided Radiologic Tumor Measurement and Evaluation of Tumor Response
Hongsen Li, Jiaying Shen, Jiawei Shou, et al.
Therapeutic Advances in Medical Oncology
|
April 7, 2023
A phase Ia dose-escalation trial of Ametumumab (a fully human monoclonal antibody against epidermal growth factor receptor) in patients with advanced solid malignancies
Da Li, Hong Pan, Wei Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 18, 2022
Alpha-Fetoprotein as a Potential Surrogate Biomarker for Atezolizumab + Bevacizumab Treatment of Hepatocellular Carcinoma
Andrew X Zhu, Farshid Dayyani, Chia-Jui Yen, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
February 22, 2014
Bevacizumab plus capecitabine and cisplatin in Chinese patients with inoperable locally advanced or metastatic gastric or gastroesophageal junction cancer: randomized, double-blind, phase III study (AVATAR study)
Lin Shen, Jin Li, Jianming Xu, et al.
Page
of 27